LOGIN
Etoricoxib versus placebo for knee osteoarthritis
May 2018
Etoricoxib versus placebo for knee osteoarthritis
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A
Fourteen days of etoricoxib 60 mg improves pain, hyperalgesia and physical function in individuals with knee osteoarthritis: a randomized controlled trial
Osteoarthritis Cartilage. 2017 Nov;25(11):1781-1791Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
86 patients with symptomatic knee osteoarthritis were randomized to etoricoxib 60mg daily for 14 days or placebo for 14 days. Patients were assessed for outcome related to resting and dynamic pain, stiffness, function, and pressure pain threshold after 4 and 14 days of treatment. Results demonstrated significantly greater improvement after 14 days in the etoricoxib group compared to the placebo gr...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.